Currently, biomarkers commonly used for retinopathy risk prediction include traditional markers such as HbA1c and blood pressure, as well as emerging biomarkers such as neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), and C-reactive protein (CRP) and so on (4, 5). The gene discussed is CRP; the disease is retinal disorder.